Page last updated: 2024-11-03

procarbazine and Leukemia, Erythroblastic, Acute

procarbazine has been researched along with Leukemia, Erythroblastic, Acute in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mantovani, G1
Del Giacco, GS1
Marongiu, F1
Tognella, S1
Carassi, UE1
Steel, NR1
Carr, D1
Finney, RD1

Other Studies

2 other studies available for procarbazine and Leukemia, Erythroblastic, Acute

ArticleYear
Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
    Acta haematologica, 1982, Volume: 67, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Leukemia, Er

1982
Erythroleukaemia following treatment of Hodgkin's disease.
    Clinical and laboratory haematology, 1982, Volume: 4, Issue:4

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combinati

1982